263 related articles for article (PubMed ID: 37536616)
21. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
[TBL] [Abstract][Full Text] [Related]
22. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.
Pamer EG
Science; 2016 Apr; 352(6285):535-8. PubMed ID: 27126035
[TBL] [Abstract][Full Text] [Related]
23. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
[TBL] [Abstract][Full Text] [Related]
24. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
[TBL] [Abstract][Full Text] [Related]
25. Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.
Huang C; Feng S; Huo F; Liu H
Microbiol Spectr; 2022 Apr; 10(2):e0190421. PubMed ID: 35311555
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota as an "invisible organ" that modulates the function of drugs.
Li X; Liu L; Cao Z; Li W; Li H; Lu C; Yang X; Liu Y
Biomed Pharmacother; 2020 Jan; 121():109653. PubMed ID: 31810138
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
28. Control of pathogens and pathobionts by the gut microbiota.
Kamada N; Chen GY; Inohara N; Núñez G
Nat Immunol; 2013 Jul; 14(7):685-90. PubMed ID: 23778796
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
31. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner.
Montassier E; Valdés-Mas R; Batard E; Zmora N; Dori-Bachash M; Suez J; Elinav E
Nat Microbiol; 2021 Aug; 6(8):1043-1054. PubMed ID: 34226711
[TBL] [Abstract][Full Text] [Related]
32. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
33. The gut microbiota, its relationship to the immune system, and possibilities of its modulation.
Lukáčová I; Ambro Ľ; Dubayová K; Mareková M
Epidemiol Mikrobiol Imunol; 2023; 72(1):40-53. PubMed ID: 37185024
[TBL] [Abstract][Full Text] [Related]
34. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory Bowel Diseases and Gut Microbiota.
Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
[TBL] [Abstract][Full Text] [Related]
36. Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.
Vitetta L; Vitetta G; Hall S
Front Immunol; 2018; 9():2240. PubMed ID: 30356736
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic resistance in the commensal human gut microbiota.
Lamberte LE; van Schaik W
Curr Opin Microbiol; 2022 Aug; 68():102150. PubMed ID: 35490629
[TBL] [Abstract][Full Text] [Related]
38. Probiotics in Medicine: A Long Debate.
Stavropoulou E; Bezirtzoglou E
Front Immunol; 2020; 11():2192. PubMed ID: 33072084
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiome and aging nexus and underlying mechanism.
Shi X; Ma T; Sakandar HA; Menghe B; Sun Z
Appl Microbiol Biotechnol; 2022 Sep; 106(17):5349-5358. PubMed ID: 35882675
[TBL] [Abstract][Full Text] [Related]
40. Role of microbial secreted proteins in gut microbiota-host interactions.
Vidal-Veuthey B; González D; Cárdenas JP
Front Cell Infect Microbiol; 2022; 12():964710. PubMed ID: 35967863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
